TIMING NEW HSIAO FENG SAN EXTRACT GRANULES 말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

timing new hsiao feng san extract granules

timing herbs sdn bhd - angelica sinensis; rehmannia glutinosa; saposhnikovia divaricata; cryptotympana pustulata; anemarrhena asphodeloides; sophora flavescens; sesamum indicum; schizonepeta tenuifolia; atractylodes lancea; arctium lappa; gypsum fibrosum; glycyrrhiza uralensis -

LIONBALL XIAOER QIXINGCHA GRANULES 말레이시아 - 영어 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

lionball xiaoer qixingcha granules

nang hin medical sdn. bhd. - coix lacryma-jobi; crataegus pinnatifida; cryptotympana pustulata; glycyrrhiza uralensis; lophatherum gracile; uncaria rhynchophylla; oryza sativa -

SOOLANTRA ivermectin 10 mg/g cream tube 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

soolantra ivermectin 10 mg/g cream tube

galderma australia pty ltd - ivermectin, quantity: 10 mg/g - cream - excipient ingredients: glycerol; isopropyl palmitate; carbomer copolymer (type b); dimeticone 20; disodium edetate; citric acid monohydrate; cetyl alcohol; stearyl alcohol; ceteareth-20; sorbitan stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; phenoxyethanol; propylene glycol; oleyl alcohol; sodium hydroxide; purified water - soolantra is indicated for the topical treatment of inflammatory lesions of rosacea (papulo-pustular) in adult patients 18 years and over.

CONTAGIOUS PUSTULAR DERMATITIS (SCABBY MOUTH VIRUS)(LIVING) 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

contagious pustular dermatitis (scabby mouth virus)(living)

zoetis australia pty ltd - contagious pustular dermatitis virus, living, cell cultu - unknown - contagious pustular dermatitis virus, living, cell cultu vaccine-viral active 0.0 - active constituent

Hepa-Merz Granulate 몰타 - 영어 - Medicines Authority

hepa-merz granulate

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - granules for oral solution - l-ornithine 3 g/5g l-aspartate 3 g/5g - bile and liver therapy

SCABIVAX CONTAGIOUS PUSTULAR DERMATITIS (ORF) VACC 아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

scabivax contagious pustular dermatitis (orf) vacc

schering plough limited - contagious pustular dermatitis vaccine - suspension for skin scarification - ovine - immunological - live vaccine

SCABIGARD SCABBY MOUTH VACCINE CONTAGIOUS PUSTULAR DERMATITIS VACCINE (LIVING) TISSUE CULTURE 오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

scabigard scabby mouth vaccine contagious pustular dermatitis vaccine (living) tissue culture

csl limited - contagious pustular dermitis virus - immunotherapy - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - not applicable (vet)

SCABIGARD 뉴질랜드 - 영어 - Ministry for Primary Industries

scabigard

zoetis new zealand limited - contagious pustular dermatitis virus - contagious pustular dermatitis virus 0 vaccine - vaccine

CIPLA IMATINIB ADULT imatinib (as mesilate) 100 mg capsules blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

cipla imatinib adult imatinib (as mesilate) 100 mg capsules blister pack

cipla australia pty ltd - imatinib mesilate, quantity: 119.5 mg (equivalent: imatinib, qty 100 mg) - capsule - excipient ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - ? treatment of patients with chronic myeloid leukaemia (cml) ? treatment of adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy ? treatment of adult patients with relapsed or refractory ph+ all as monotherapy ? treatment of adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements, where conventional therapies have failed ? treatment of adult patients with aggressive systemic mastocytosis (asm), where conventional therapies have failed ? treatment of adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) ? adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (dfsp).